High-Purity 3-(2-Chloropyrimidin-4-yl)-1-Methylindole: A Key Osimertinib Intermediate
Unlock advanced cancer therapies with our high-purity intermediate, crucial for Osimertinib synthesis.
Get a Quote & SampleProduct Core Value
3-(2-chloropyrimidin-4-yl)-1-methylindole
This compound is a critical building block in the synthesis of Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Its precise chemical structure enables the formation of Osimertinib’s complex molecular framework, ensuring efficacy and safety in clinical use for treating non-small cell lung cancer.
- As a key 3-(2-chloropyrimidin-4-yl)-1-methylindole CAS 1032452-86-0, its high purity (≥99.0% by HPLC) is paramount for pharmaceutical applications.
- The synthesis of advanced therapeutic agents like Osimertinib relies heavily on intermediates like this, facilitating targeted cancer therapies.
- Ensuring stringent impurity control, with a maximum single impurity of ≤0.5%, is vital for the quality of the final drug product.
- This chemical intermediate for targeted therapy supports the development of next-generation cancer treatments by providing a reliable molecular foundation.
Key Advantages
Exceptional Purity
Achieve reliable drug synthesis with our intermediate, boasting ≥99.0% purity, essential for meeting stringent API intermediate synthesis standards.
Critical Pharmaceutical Role
Facilitate the production of life-saving medications; this compound is an indispensable part of advanced therapeutic agent building blocks for modern medicine.
Uncompromised Quality Control
Benefit from meticulous manufacturing processes ensuring low moisture and minimal impurities, critical for the integrity of your final product in API synthesis.
Key Applications
Osimertinib Synthesis
Essential for creating Osimertinib, a drug that targets specific EGFR mutations, thereby offering a crucial component in advanced cancer therapy development.
API Intermediate Production
Serves as a vital link in the complex chain of producing Active Pharmaceutical Ingredients (APIs), enabling efficient and high-quality manufacturing.
Targeted Cancer Therapies
Plays a pivotal role in developing and manufacturing drugs that precisely target cancer cells, contributing to improved patient outcomes in oncology.
Pharmaceutical Research & Development
A valuable compound for R&D, allowing exploration into new therapeutic agents and synthetic pathways within the pharmaceutical industry.